Viewing Study NCT02293902


Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2026-04-22 @ 9:55 AM
Study NCT ID: NCT02293902
Status: COMPLETED
Last Update Posted: 2018-01-30
First Post: 2014-11-13
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI)
Sponsor: Sanofi
Organization: